Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Liver Diseases

  Free Subscription


Articles published in Transplant Proc

Retrieve available abstracts of 82 articles:
HTML format



Single Articles


    September 2025
  1. HASEGAWA Y, Obara H, Ojiro K, Kitago M, et al
    Trends and Barriers in Liver Transplantation for Patients With Decompensated Cirrhosis: A 15-Year Single-Center Cohort at a Japanese Center.
    Transplant Proc. 2025 Sep 16:S0041-1345(25)00453.
    PubMed     Abstract available


  2. EGELI T, Unek T, Ozbilgin M, Agalar C, et al
    Evaluation of Etiology Based on Post-Transplant Pathological Diagnosis in Cases of Cryptogenic Cirrhosis.
    Transplant Proc. 2025 Sep 16:S0041-1345(25)00384.
    PubMed     Abstract available


    August 2025
  3. AGALAR C, Egeli T, Aysal A, Ozbilgin M, et al
    HALP Score Predicts Early Post-Transplant Outcomes: A 25-Year Retrospective Study on Hepatocellular Carcinoma and Liver Transplantation Outcomes.
    Transplant Proc. 2025 Aug 30:S0041-1345(25)00372.
    PubMed     Abstract available


  4. AGALAR C, Egeli T, Ozbilgin M, Sakaoglu B, et al
    Pathologic Complete Response as a Prognostic Indicator in Bridging Therapy: A 25-Year Retrospective Study on Hepatocellular Carcinoma and Liver Transplantation Outcomes.
    Transplant Proc. 2025 Aug 30:S0041-1345(25)00375.
    PubMed     Abstract available


  5. KIM J, Hong SK, Lee A, Kumar SN, et al
    Activity-Dependent Effects of ERK1/2 on Hepatic Ischemia-Reperfusion Injury.
    Transplant Proc. 2025 Aug 11:S0041-1345(25)00350.
    PubMed     Abstract available


  6. WANG X, Xing N, Yang Q, Ding P, et al
    Catastrophic Outcome of Suspected Seventh-Day Syndrome After Liver Transplantation: Case Report and Literature Review.
    Transplant Proc. 2025 Aug 9:S0041-1345(25)00370.
    PubMed     Abstract available


    July 2025
  7. BEYZAEI Z, Bagheri Z, Karimzadeh S, Geramizadeh B, et al
    Comparison of Histological Analysis and Gross Assessment for Detection of Donor Liver Macrovesicular Steatosis in Liver Transplantation: A Systematic Review and Meta-Analysis.
    Transplant Proc. 2025 Jul 2:S0041-1345(25)00296.
    PubMed     Abstract available


    June 2025
  8. BARDAK AE, Cifcibasi Ormeci A, Yildiz Z, Senkal V, et al
    Anxiety and Depression Outcomes in Liver Transplant Candidates and Recipients Using the Hospital Anxiety and Depression Scale.
    Transplant Proc. 2025 Jun 26:S0041-1345(25)00294.
    PubMed     Abstract available


  9. ROSELLI S, Panzera P, Valentini MF, Gigante G, et al
    Sonographic Hepatosplenic Ratio: A Noninvasive Method to Diagnose Graft Steatosis in Liver Transplantation.
    Transplant Proc. 2025 Jun 19:S0041-1345(25)00276.
    PubMed     Abstract available


  10. XIONG Y, Fan L, Tu Q, Peng G, et al
    Corrigendum to "Cytochrome b5 Interacts With Cytochrome C and Inhibits Hepatocyte Apoptosis in Brain-dead Rabbit Donors" [Transplantation Proceedings, 51/6 2019: 2108-2115].
    Transplant Proc. 2025 Jun 11:S0041-1345(25)00269.
    PubMed    


  11. SINAN EFE Y, Ahmet A, Ebru T, Tolga S, et al
    Echinococcal Liver Infections: Comparing Transplant Strategies for Granulosus and Alveolaris.
    Transplant Proc. 2025;57:916-921.
    PubMed     Abstract available


    April 2025
  12. YONDER H, Tatli F, Berhuni MS, Elkan H, et al
    Recommendations for Hepatic Artery Anastomosis in Liver Transplantation: A Group Experience.
    Transplant Proc. 2025 Apr 28:S0041-1345(25)00197.
    PubMed     Abstract available


  13. KAHVECI AS, Aslam A, Xiong Y, Tanaka T, et al
    De-Novo Hepatic Angiosarcoma in a Liver Transplant Recipient.
    Transplant Proc. 2025 Apr 26:S0041-1345(25)00233.
    PubMed     Abstract available


    March 2025
  14. FU S, Pan JH, Kadri H, Contag C, et al
    Perioperative Outcomes of Limited Sobriety Versus Standard Sobriety Liver Transplantation for Alcohol-associated Liver Disease.
    Transplant Proc. 2025 Mar 19:S0041-1345(25)00138.
    PubMed     Abstract available


  15. GAO W, Zhang Q, Ma L, He N, et al
    The Safety Evaluation of TAE for Ruptured Hepatocellular Carcinoma and Ablation-Related Hemorrhage, and the Clinical Significance of Postoperative Liver Function Changes.
    Transplant Proc. 2025 Mar 18:S0041-1345(25)00142.
    PubMed     Abstract available


  16. OCAK I, Colak M, Bilici BN
    Comparative Analysis of Plasmapheresis Versus Plasmapheresis Combined With Continuous Renal Replacement Therapy in Adult Liver Failure: A Retrospective Observational Study.
    Transplant Proc. 2025 Mar 17:S0041-1345(25)00140.
    PubMed     Abstract available


  17. ZHANG S, Zhang S
    Successful Liver Transplantation After Achieving Complete Clinical Remission of Hepatocellular Carcinoma With Combination Therapy of Immune Checkpoint Inhibitors and Targeted Agents: A Case Report.
    Transplant Proc. 2025 Mar 13:S0041-1345(25)00137.
    PubMed     Abstract available


  18. WANG H, Qu W, Liu Y, Zhang L, et al
    Recurrence of Myopathy After Liver Transplantation for Patients With End-Stage GSD Type IIIa.
    Transplant Proc. 2025 Mar 3:S0041-1345(25)00093.
    PubMed     Abstract available


    February 2025
  19. SEMAAN S, Connor AA, Saharia A, Kodali S, et al
    Transplantation for Peri-Hilar and Intrahepatic Cholangiocarcinoma With mTOR Immunosuppression.
    Transplant Proc. 2025 Feb 11:S0041-1345(25)00057.
    PubMed     Abstract available


    January 2025
  20. WANG W, Wang B, Lin T, Zhang Y, et al
    Distribution, Drug Resistance, and Risk Factors of Infection in Liver Transplant Recipients With Liver Failure.
    Transplant Proc. 2025 Jan 31:S0041-1345(25)00006.
    PubMed     Abstract available


  21. RODRIGUEZ-VILLAR C, Pulgarin AT, Arda RR, Paredes-Zapata D, et al
    Usefulness of Portable Ultrasound for the Diagnosis of Hepatic Steatosis and Degree of Agreement With Macroscopic and Microscopic Findings of the Hepatic Graft Accepted for Transplantation.
    Transplant Proc. 2025 Jan 8:S0041-1345(24)00665.
    PubMed     Abstract available


  22. VICENTE TP, Valero AP, Tamayo BV, Ordorica PR, et al
    Liver Transplantation for Polycystic Disease: Experience and Results of a Single-Center Series.
    Transplant Proc. 2025 Jan 8:S0041-1345(24)00661.
    PubMed     Abstract available


  23. ROSELLO AP, Chullo G, Pera M, Bataller R, et al
    Danger Biomarkers in Perfusates From Fatty Liver Grafts Subjected to Cold Storage Preservation in Different Preservation Solutions.
    Transplant Proc. 2025;57:37-42.
    PubMed     Abstract available


    December 2024
  24. DINCKAN A, Eren E, Ensaroglu F, Sahin T, et al
    Paired Exchange Living Donor Liver Transplantation: A Single Center Experience From Turkiye.
    Transplant Proc. 2024 Dec 7:S0041-1345(24)00543.
    PubMed     Abstract available


  25. YAMADA Y, Furukawa K, Haruki K, Onda S, et al
    Gun-Sight Technique With Dual Hepatic Vascular Embolization for Sigmoidal Refractory Biliary Stricture After Living-Donor Liver Transplantation: A Case Report.
    Transplant Proc. 2024 Dec 2:S0041-1345(24)00578.
    PubMed     Abstract available


    November 2024
  26. BROMBOSZ EW, Hobeika MJ, Kodali S, Connor AA, et al
    Outcomes of Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation Utilizing Extended Criteria Donor Grafts.
    Transplant Proc. 2024 Nov 30:S0041-1345(24)00568.
    PubMed     Abstract available


  27. ERBIS H, Kilinc EM, Firat AC, Aliosmanoglu C, et al
    Outcomes of Liver Transplantation in Infants: A Retrospective Cohort Study.
    Transplant Proc. 2024 Nov 29:S0041-1345(24)00562.
    PubMed     Abstract available


  28. PALOYO SR, David-Paloyo FP, Liquete RMR, Ona ET, et al
    Liver Transplantation in the Philippines: Light at the End of the Tunnel.
    Transplant Proc. 2024 Nov 25:S0041-1345(24)00550.
    PubMed     Abstract available


  29. DE AVILA AC, Matos Fernandes L, Pola Dos Reis F, Lucas Dos Santos S, et al
    Lung transplantation for alpha-1-antitrypsin deficiency and Behcet's disease: A case report.
    Transplant Proc. 2024 Nov 6:S0041-1345(24)00541.
    PubMed     Abstract available


    September 2024
  30. RADOVITCH H, Le Sagere S, Cabarrou B, Maulat C, et al
    Influence of the Radiological Response on Histological Necrosis and on the Survival of Patients Treated With Transarterial Chemoembolization for Hepatocellular Carcinoma Secondary to Cirrhosis on the Liver Transplantation Waiting List.
    Transplant Proc. 2024 Sep 5:S0041-1345(24)00468.
    PubMed     Abstract available


  31. TEKBAS A, Schilling K, Fahrner R, Morath O, et al
    Liver Transplantation for Budd-Chiari Syndrome From Myeloproliferative Neoplasms - Management and Long-Term Results.
    Transplant Proc. 2024 Sep 4:S0041-1345(24)00462.
    PubMed     Abstract available


    August 2024
  32. NEWMAN MT, Mittal R, La Barba D, Sahota A, et al
    Remote Hepatocellular Carcinoma Recurrence to Lumbar Spine Post Orthotopic Liver Transplantation-A Report of Two Cases and a Review of the Literature.
    Transplant Proc. 2024 Aug 26:S0041-1345(24)00439.
    PubMed     Abstract available


  33. ANILIR E
    Evaluation of Factors Affecting Rehospitalization and Survival After Living Donor Liver Transplantation.
    Transplant Proc. 2024 Aug 26:S0041-1345(24)00434.
    PubMed     Abstract available


  34. AHMED H, Atiq M, Salih M, Bhatti AB, et al
    Impact of Sarcopenia on Post-Liver Transplant Hospitalization: Insights From a South Asian Cohort.
    Transplant Proc. 2024 Aug 24:S0041-1345(24)00445.
    PubMed     Abstract available


  35. TAKAHASHI K, Ozawa E, Miyaaki H, Hara T, et al
    Fully-Covered Self-Expandable Metal Stent for Hepaticojejunostomy Anastomotic Stricture After Living Donor Liver Transplantation: A Case Series.
    Transplant Proc. 2024 Aug 23:S0041-1345(24)00428.
    PubMed     Abstract available


  36. KOH ZJ, Wu AG, Yew A, Lee YY, et al
    Systematic Review and Meta-Analysis of the Outcomes After Hepatic Artery Reconstruction in Pediatric Liver Transplantation Using a Microscope Versus Surgical Loupe.
    Transplant Proc. 2024 Aug 19:S0041-1345(24)00425.
    PubMed     Abstract available


    July 2024
  37. PANG L, Xu LB, Wu WR
    Downstaging of Hepatocellular Carcinoma Before Liver Transplantation: Current Advances in Selection Criteria and Therapeutic Options.
    Transplant Proc. 2024 Jul 31:S0041-1345(24)00353.
    PubMed     Abstract available


  38. MARIN-CASTRO P, Waisberg DR, Rocha-Santos V, Pinheiro RS, et al
    En Bloc Simultaneous Liver-Kidney Transplantation Compared to the Traditional Technique: Results From a Single Center.
    Transplant Proc. 2024 Jul 23:S0041-1345(24)00282.
    PubMed     Abstract available


  39. THULUVATH AJ, Kim M, Peipert J, Duarte-Rojo A, et al
    Patient-Reported Outcome Screens for Cognitive Dysfunction and Predicts Admissions in Cirrhosis.
    Transplant Proc. 2024 Jul 17:S0041-1345(24)00326.
    PubMed     Abstract available


  40. WANG N, Zhu Z, Zheng H, Qi C, et al
    Diagnosis and Treatment of Hepatic Hematoma After Liver Transplantation in a Timely Manner.
    Transplant Proc. 2024 Jul 13:S0041-1345(24)00343.
    PubMed     Abstract available


  41. DE ATAIDE EC, Perales SR, Bento APN, Teramoto FD, et al
    Silent Destruction: Fulminant Hepatitis and the Hidden Danger of Weight Loss Drugs.
    Transplant Proc. 2024 Jul 4:S0041-1345(24)00268.
    PubMed     Abstract available


  42. WU J, Zhang X, Qin B, Qiu X, et al
    Incidence, Etiology and Prognosis of Initial Liver Injury After Allogeneic Hematopoietic Stem Cell Transplantation: A Multi-Center Retrospective Study.
    Transplant Proc. 2024;56:1436-1445.
    PubMed     Abstract available


    June 2024
  43. DE ATAIDE EC, Perales SR, Teramoto FD, Foratto A, et al
    Liver Transplantation After Previous Vena Cava Resection: Case Report.
    Transplant Proc. 2024 Jun 21:S0041-1345(24)00266.
    PubMed     Abstract available


  44. YOU MW, Chuang SC, Liang HR, Chuang SH, et al
    Tacrolimus-Induced Hepatic Vein Occlusive Disease After Deceased Donor Liver Transplantation: A Case Report.
    Transplant Proc. 2024 Jun 17:S0041-1345(24)00276.
    PubMed     Abstract available


  45. ALMEIDA JD, Waisberg DR, Martino RB, Rocha-Santos V, et al
    Retransplantation for Late Hepatic Artery Thrombosis: Results from a Single Center.
    Transplant Proc. 2024 Jun 10:S0041-1345(24)00262.
    PubMed     Abstract available


  46. VIEIRA IF, Waisberg DR, Rocha-Santos V, Pinheiro RS, et al
    Liver Transplantation for Benign Massive Hepatomegaly: Results From a Single Center and Contribution of the Left-to-Right Piggyback Approach.
    Transplant Proc. 2024 Jun 10:S0041-1345(24)00267.
    PubMed     Abstract available


  47. ALVAREZ J, Waisberg DR, Ducatti L, Rocha-Santos V, et al
    Liver Transplantation for Adenomatosis: A Single-Center Experience.
    Transplant Proc. 2024 Jun 10:S0041-1345(24)00261.
    PubMed     Abstract available


    May 2024
  48. SILVA MS, Waisberg DR, Caldas TG, Martino RB, et al
    Life-Threatening Ruptured Hepatic Artery Pseudoaneurysm Post-Liver Transplant: A Case Report.
    Transplant Proc. 2024 May 13:S0041-1345(24)00256.
    PubMed     Abstract available


  49. JABIRY-ZIENIEWICZ Z, Stelmach DA, Jasak K, Knap-Wielgus W, et al
    Pregnancies in Women After Liver Transplant due to Wilson's Disease-Case Series.
    Transplant Proc. 2024 May 9:S0041-1345(24)00249.
    PubMed     Abstract available


  50. JABIRY-ZIENIEWICZ Z, Stelmach DA, Jasak K, Knap-Wielgus W, et al
    Pregnancy in Liver and Kidney Female Recipient: A Case Report.
    Transplant Proc. 2024;56:998-999.
    PubMed     Abstract available


  51. CZARNECKA K, Czarnecka P, Tronina O, Baczkowska T, et al
    MASH Continues as a Significant Burden on Metabolic Health of Liver Recipients.
    Transplant Proc. 2024;56:822-831.
    PubMed     Abstract available


    April 2024
  52. KANG SW, Ban JY, Park MS
    Protective Role of Rapamycin in Fibrotic Liver Ischemia/Reperfusion Injury (C57bl/6 Mouse).
    Transplant Proc. 2024;56:672-677.
    PubMed     Abstract available


  53. KANG HG, Park H, Myong GE, Kim WJ, et al
    Beneficial Effect of Rapamycin on Liver Fibrosis in a Mouse Model (C57bl/6 Mouse).
    Transplant Proc. 2024;56:701-704.
    PubMed     Abstract available


    March 2024
  54. ZHAN HS, Wei L, Liu JY, Xiong HF, et al
    Favorable Outcomes of Liver Transplantation for Hepatopulmonary Syndrome.
    Transplant Proc. 2024 Mar 22:S0041-1345(24)00165.
    PubMed     Abstract available


  55. LIM WX, Sim KS, Chen CL, Ou HY, et al
    Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma: The Effectiveness of Different Particle Sizes in Downstaging and Bridging in Living Donor Liver Transplantation.
    Transplant Proc. 2024 Mar 11:S0041-1345(24)00084.
    PubMed     Abstract available


  56. IMAOKA K, Ohira M, Hattori M, Chogahara I, et al
    Immunotherapy Using Activated Natural Killer Cells Improves Postoperative Neutrophil-to-Lymphocyte Ratio and Long-Term Prognosis of Living Donor Liver Transplant Recipients With Hepatocellular Carcinoma.
    Transplant Proc. 2024 Mar 4:S0041-1345(24)00129.
    PubMed     Abstract available


    February 2024
  57. COSTA PEG, Garcia JHP, Coelho GR, Barros MAP, et al
    Hepatocellular Carcinoma in Ceara: Epidemiology and Treatment in a Reference Liver Transplant Center in Northeast Brazil.
    Transplant Proc. 2024 Feb 28:S0041-1345(24)00009.
    PubMed     Abstract available


  58. HO CT, Vu VQ, Dang KK, Pham HM, et al
    Effect of Donors' Biliary Variation on Postoperative Biliary Complications in Living Donor Liver Transplantation: A Single-Center Observational Study in Vietnam.
    Transplant Proc. 2024 Feb 23:S0041-1345(24)00065.
    PubMed     Abstract available


  59. UENO T, Takase K, Deguchi K, Nomura M, et al
    Clinical Implications of Serum Mac-2 Binding Protein in Patients After Living Donor Liver Transplantation for Biliary Atresia.
    Transplant Proc. 2024 Feb 14:S0041-1345(24)00006.
    PubMed     Abstract available


  60. RODRIGUEZ-ESPINOSA D, Morantes L, Garcia J, Broseta JJ, et al
    Long-Term Outcomes of Incidental Liver Malignancies in Simultaneous Liver-Kidney Transplant Recipients.
    Transplant Proc. 2024 Feb 12:S0041-1345(24)00004.
    PubMed     Abstract available


  61. BEKKI T, Ohira M, Chogahara I, Imaoka K, et al
    Association of Abdominal Aortic Calcification With the Postoperative Metabolic Syndrome Components After Liver Transplantation.
    Transplant Proc. 2024 Feb 7:S0041-1345(24)00016.
    PubMed     Abstract available


  62. WU MY, Yeh CH, Liao CC, Chen CL, et al
    Sarcopenia Affects Liver Regeneration and Long-Term Survival Rate After Living-Donor Liver Transplantation in Patients With Hepatocellular Carcinoma.
    Transplant Proc. 2024 Feb 6:S0041-1345(23)00794.
    PubMed     Abstract available


  63. SEO CH, Choi HJ, Na GH
    Liver Transplantation at a Small Volume Center-The Role of Network System.
    Transplant Proc. 2024 Feb 5:S0041-1345(24)00037.
    PubMed     Abstract available


    January 2024
  64. KIM SM, Yoon YI, Moon DB, Kim KH, et al
    Achieving 400 Living Donor Liver Transplantations Annually During the COVID-19 Pandemic: A Single-Center Experience.
    Transplant Proc. 2024 Jan 31:S0041-1345(23)00788.
    PubMed     Abstract available


  65. ISHII M, Hirukawa K, Shimata K, Yoshimaru Y, et al
    The First Successful Living Donor Liver Transplantation for Acute-on-Chronic Liver Failure Caused by Severe Acute Necrotizing Pancreatitis: A Case Report.
    Transplant Proc. 2024 Jan 12:S0041-1345(23)00775.
    PubMed     Abstract available


  66. ANILIR E, Oral A, Turker F, Sahin T, et al
    Predictive Value of Preoperative 18 Fludeoxyglucose Positron Emission Tomography-Computed Tomography for Survival in Liver Transplantation Due to Hepatocellular Cancer.
    Transplant Proc. 2024 Jan 10:S0041-1345(23)00787.
    PubMed     Abstract available


  67. NAGATA R, Akamatsu N, Shibata E, Takao H, et al
    Metallic Stents for Hepatic Venous Outflow Obstruction After Living-Donor Liver and Their Therapeutic Effects.
    Transplant Proc. 2024 Jan 3:S0041-1345(23)00750.
    PubMed     Abstract available


    December 2023
  68. CUEVAS LOPEZ MJ, Bellido CB, Franco CC, Artacho GS, et al
    Emergency Liver Retransplantation With Marginal Donors.
    Transplant Proc. 2023;55:2282-2284.
    PubMed     Abstract available


  69. ZHANG X, Dutton M, Liu R, Ali AA, et al
    Deep Learning-Based Survival Analysis for Receiving a Steatotic Donor Liver Versus Waiting for a Standard Liver.
    Transplant Proc. 2023;55:2436-2443.
    PubMed     Abstract available


    November 2023
  70. ISHA S, Jenkins AS, Hanson AJ, Satashia PH, et al
    The Effect of Molecular Adsorbent Recirculating System in Patients With Liver Failure: A Case Series of 44 Patients.
    Transplant Proc. 2023;55:2126-2133.
    PubMed     Abstract available


    October 2023
  71. BURGOS MM, Grande RG, Ortega SL, Leiva IS, et al
    Analysis of the Survival of Patients Transplanted for Hepatocarcinoma According to Age at Transplantation.
    Transplant Proc. 2023 Oct 27:S0041-1345(23)00597.
    PubMed     Abstract available


  72. MI H, Fang J, Wu S, Mao S, et al
    Comparison of Postoperative Hemorrhage Risk After Partial Liver Transplantation Versus Whole Liver Transplantation: A Single-Center Experience.
    Transplant Proc. 2023 Oct 25:S0041-1345(23)00634.
    PubMed     Abstract available


  73. PAHARI H, Raj A, Sonavane A, Sawant A, et al
    Liver Transplantation for Acute Liver Failure Due to Yellow Phosphorus Poisoning - A Comprehensive Review.
    Transplant Proc. 2023 Oct 23:S0041-1345(23)00635.
    PubMed     Abstract available


  74. LEE JE, Jung H, Byun SH, Park JM, et al
    Effect of Dexmedetomidine Preconditioning on Hepatic Ischemia-Reperfusion Injury in Acute Hyperglycemic Rats.
    Transplant Proc. 2023 Oct 20:S0041-1345(23)00640.
    PubMed     Abstract available


  75. SANCHEZ AIF, Reyes MP, Perez BS, Villalba JS, et al
    Liver Transplant With Double Portal Anastomose: A Case Report.
    Transplant Proc. 2023 Oct 11:S0041-1345(23)00591.
    PubMed     Abstract available


  76. CHAIRI MHM, Arias ABV, Zurbano MS, Rios PD, et al
    Reassessment After Locoregional Treatment of Hepatocellular Carcinoma Previous Liver Transplantation: Is MRI Necessary for All Patients?
    Transplant Proc. 2023 Oct 7:S0041-1345(23)00588.
    PubMed     Abstract available


  77. KIM DH, Park SJ, Oh SH, Jhang WK, et al
    Disseminated Intravascular Coagulation as a Risk Factor for Clinical Outcome After Liver Transplantation in Pediatric Patients With Kasai Portoenterostomy Failure.
    Transplant Proc. 2023 Oct 6:S0041-1345(23)00562.
    PubMed     Abstract available


    September 2023
  78. BEZINOVER D, Alhkouri N, Schumann R, Geyer N, et al
    Liver Transplant Outcomes in Young Adults with Cirrhosis Related to Nonalcoholic Fatty Liver Disease.
    Transplant Proc. 2023 Sep 24:S0041-1345(23)00561.
    PubMed     Abstract available


  79. DUTTA N, Marka N, Lake J, Lim N, et al
    Mortality and Cardiovascular Outcomes in Adult Non-Liver Solid Organ Transplant Patients With Nonalcoholic Steatohepatitis.
    Transplant Proc. 2023 Sep 18:S0041-1345(23)00553.
    PubMed     Abstract available


  80. SAMBOMMATSU Y, Bruno DA, Imai D, Lee SD, et al
    Domino Liver Transplantation for Unresectable Colon Cancer Liver Metastasis From a Donor With Heterozygous Familial Hyperlipidemia: A Case Report.
    Transplant Proc. 2023 Sep 1:S0041-1345(23)00481.
    PubMed     Abstract available


    August 2023
  81. ALIM A, Karatas C, Akbulut A, Oguz BH, et al
    Living Donor-Initiated Domino Split-Liver Transplantation in Pediatric Setup: A Case Report With Literature Review.
    Transplant Proc. 2023 Aug 28:S0041-1345(23)00480.
    PubMed     Abstract available


    July 2023
  82. LEE S, Yi NJ, Kwak N, Kim H, et al
    Immune Reconstitution Inflammatory Syndrome and Drug-Induced Liver Injury During Treatment of Disseminated Tuberculosis in a Liver Transplant Recipient: A Case Report.
    Transplant Proc. 2023 Jul 17:S0041-1345(23)00458.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.